attana - sensor technologies

Glimpses from the World ADC Frankfurt conference

ADC experts from industry, academic and clinical leaders exchanged in-depth knowledge during the World ADC Frankfurt conference.

Attana attended the 6th World ADC Frankfurt conference end of February (26th -28th) where ADC experts from industry, academic and clinical leaders gathered to exchange in-depth knowledge within the field. The two-day speaker agenda was set to an Industry Stream and to a Science Stream and a morning Plenary Session including those two. There were several talks and discussions about how to maximize the ADC effectiveness, how to improve the success rate by making the right decisions around antibody and target selection and how cutting-edge technology can contribute in the development of the best ADC. However, the main talk was undeniably ImmunoGen´s and Genentech´s FDA approval of the drug KadcylaTM (T-DM1), an antibody-drug conjugate compound for solid tumor indication.

On day one in the Plenary Session, Teodor Aastrup, Executive VP & Co-Founder of Attana AB, gave a presentation about "Label-Free Cell-Based Assays - A Shift Towards Biological Relevance", which generated several interesting follow up discussions. “The conference attracted the right people to facilitate state of the art discussions and we are satisfied that Attana's instruments became part of these discussions to further strengthen our position”, says Teodor Aastrup.